Great post @I.
I agree that we need to see some form of accelerated growth as a catalyst to get the share price moving forward again. The historical growth rate of 30% per annum is solid but it is accelerated growth that will take us back to 7-10c and beyond.
Don't get me wrong, I am expecting some form of accelerated growth in Q3 and Q4 (which should take us back to 6c at least) but I am not expecting anything phenomenal, simply based on historical performance and track record.
As Star points out, 16% QoQ, is the best quarterly result that 1ST has ever achieved. 16% QoQ is a very strong result (80% CAGR), but it is not world class SaaS growth.
I've not sold a cent recently and certainly don't plan to because I believe we are well below fair value and will return to 6c minimum in the coming months.
In terms of the pivot to growth from cashflow breakeven, I think this is driven off the realization that the 1ST business model is very strong (reference the LTV to CAC ratio) and that it is therefore critical that 1ST undergoes a land grab and secures as many sites as possible which will later become a huge asset for the company once they have some pricing power.
1ST is currently cashed up so I am not expecting another CR at all this year, but when the share price recovers I wouldn't rule out a CR in CY2021 if it helps push the growth agenda.
Lastly, I think 1ST has steered away from guidance and bullish forward commentary because of an understanding that moving forward, the best approach is to underpromise and overdeliver. I agree with this approach. Most microcap management teams do the opposite. It will be important for 1ST to underpromise and overdeliver from here on in.
T.E.P.
- Forums
- ASX - By Stock
- VFX
- Where is Fair Value?
VFX
visionflex group limited
Add to My Watchlist
0.00%
!
0.2¢

Where is Fair Value?, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.735M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 60908610 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 7542241 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 60908610 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 7542241 | 7 |
0.003 | 14449346 | 9 |
0.004 | 9570000 | 5 |
0.005 | 2500000 | 1 |
0.020 | 5000000 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
VFX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online